Written by Michael Sassano, CEO, Somai Pharmaceuticals On January 12, the United States Department of Health and Human Services (HHS)
SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new state-of-the-art pharmaceutical EU-GMP facility in Portugal. SOMAÍ’s phase 1 manufacturing footprint
Michael Sassano, CEO of international cannabis manufacturer Somai Pharmaceuticals, explores the state of cannabis extract manufacturing in Europe and who
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
